Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/34930 |
Resumo: | Objective: identify the main bacteria resistant to broad drugs associated with the development of pneumonia in hospital patients from 2017 to 2022 worldwide, comparing the agents identified before and during the pandemic due to COVID-19. Methodology: The articles were searched in the Scielo, PubMed and UpToDate databases following the guidelines of the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). The ‘’PVOS’’ strategy (population, variables, outcomes and study) was used to select the articles analyzed in the review. The descriptors standardized by the ‘’Descritores em Ciências da Saúde’’ were used: pneumonia, antibacterials, bacterial drug resistance, bacterial multiple drug resistance for bibliographic survey. Included in this systematic review, analytical observational studies, articles of published research, case studies, systematic reviews and epidemiological, microbiological, and molecular surveillance studies. Results: After the screening process, removal of duplicate articles and analysis of inclusion criteria, 27 articles were identified as eligible for this systematic review. Conclusion: The results of this systematic review provide evidence of the main bacteria causing pneumonia in hospitalized patients worldwide, as well as the resistance profile in the case of multidrug-resistant organisms, in addition to identifying treatment alternatives for these agents. |
id |
UNIFEI_ce80ed55c7c06ed2d13d74bdeafc63fc |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/34930 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review Resistencia bacteriana en el tratamiento de la neumonía en pacientes hospitalizados: una revisión sistemática Resistência bacteriana no tratamento de pneumonia em pacientes de unidades hospitalares: uma revisão sistemática PneumoniaFarmacorresistência bacterianaAntibacterianos.Bacterial drug resistancePneumoniaAntibacterial.NeumoníaFarmacorresistencia bacterianaAntibacteriano.Objective: identify the main bacteria resistant to broad drugs associated with the development of pneumonia in hospital patients from 2017 to 2022 worldwide, comparing the agents identified before and during the pandemic due to COVID-19. Methodology: The articles were searched in the Scielo, PubMed and UpToDate databases following the guidelines of the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). The ‘’PVOS’’ strategy (population, variables, outcomes and study) was used to select the articles analyzed in the review. The descriptors standardized by the ‘’Descritores em Ciências da Saúde’’ were used: pneumonia, antibacterials, bacterial drug resistance, bacterial multiple drug resistance for bibliographic survey. Included in this systematic review, analytical observational studies, articles of published research, case studies, systematic reviews and epidemiological, microbiological, and molecular surveillance studies. Results: After the screening process, removal of duplicate articles and analysis of inclusion criteria, 27 articles were identified as eligible for this systematic review. Conclusion: The results of this systematic review provide evidence of the main bacteria causing pneumonia in hospitalized patients worldwide, as well as the resistance profile in the case of multidrug-resistant organisms, in addition to identifying treatment alternatives for these agents.Objetivo: identificar las principales bacterias resistentes a fármacos amplios asociados al desarrollo de neumonía en pacientes hospitalarios de 2017 a 2022 a nivel mundial, comparando los agentes identificados antes y durante la pandemia por COVID-19. Metodología: Los artículos fueron buscados en las bases de datos Scielo, PubMed y UpToDate, siguiendo las pautas del Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). La estrategia ‘’PVOS’’ (population, variables, outcomes and study) se utilizó para seleccionar los artículos analizados en la revisión. Se utilizaron los descriptores estandarizados por los “Descritores em Ciências da Saúde’’: neumonía, antibacterianos, farmacorresistencia bacteriana, farmacorresistencia bacteriana múltiple para la encuesta bibliográfica. Incluidos en esta revisión sistemática, estudios observacionales analíticos, artículos de investigaciones publicadas, estudios de casos, revisiones sistemáticas y estudios epidemiológicos, microbiológicos y de vigilancia molecular. Resultados: Después del proceso de selección, la eliminación de artículos duplicados y el análisis de los criterios de inclusión, se identificaron 27 artículos como elegibles para esta revisión sistemática. Conclusión: Los resultados de esta revisión sistemática proporcionan evidencia de las principales bacterias causantes de neumonía en pacientes hospitalizados a nivel mundial, así como el perfil de resistencia en el caso de organismos multirresistentes, además de identificar alternativas de tratamiento para estos agentes.Objetivo: identificar quais são as principais bactérias resistentes a amplos medicamentos associadas ao desenvolvimento de pneumonia em pacientes de unidades hospitalares no período de 2017 a 2022 a nível mundial, comparando os agentes identificados antes e durante a pandemia devido a COVID-19. Metodologia: A pesquisa dos artigos foi realizada nas bases de dados Scielo, PubMed e UpToDate, sendo utilizadas as normas do Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). A estratégia ‘’PVOS’’ (population, variables, outcomes and study) foi utilizada para selecionar os artigos analisados na revisão. Foram utilizados os descritores padronizados pelos ‘’Descritores em Ciências da Saúde’’: pneumonia, antibacterianos, farmacorresistência bacteriana, farmacorresistência bacteriana múltipla para o levantamento bibliográfico. Foram incluídos nessa revisão sistemática estudos observacionais analíticos, artigos de pesquisa publicados, estudos de caso, revisões sistemáticas e estudos de vigilância epidemiológica, microbiológica, e molecular. Resultados: Após o processo de triagem, remoção de artigos duplicados e análises dos critérios de inclusão, 27 artigos foram identificados como elegíveis para esta revisão sistemática. Conclusão: Os resultados desta revisão sistemática fornecem evidências das principais bactérias causadoras de pneumonia em pacientes hospitalizados a nível mundial, bem como o perfil de resistência em caso de organismos multirresistentes, além de identificar alternativas de tratamento para esses agentes.Research, Society and Development2022-09-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3493010.33448/rsd-v11i13.34930Research, Society and Development; Vol. 11 No. 13; e25111334930Research, Society and Development; Vol. 11 Núm. 13; e25111334930Research, Society and Development; v. 11 n. 13; e251113349302525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/34930/29438Copyright (c) 2022 Lucas Cerqueira Gomes Barbosa do Nascimento; Gledson Lima Alves Junior; Vitor Moura Pereira; Gerlan da Silva Rodrigues ; Adriano Bezerra da Silva Júnior; André Luís Conceição Lemos; Rafael Valença de Souza Santos; Adriel Barbosa do Nascimentohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Nascimento, Lucas Cerqueira Gomes Barbosa doAlves Junior, Gledson LimaPereira, Vitor MouraRodrigues , Gerlan da Silva Silva Júnior, Adriano Bezerra da Lemos, André Luís Conceição Santos, Rafael Valença de Souza Nascimento, Adriel Barbosa do 2022-10-17T13:43:46Zoai:ojs.pkp.sfu.ca:article/34930Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:01.902646Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review Resistencia bacteriana en el tratamiento de la neumonía en pacientes hospitalizados: una revisión sistemática Resistência bacteriana no tratamento de pneumonia em pacientes de unidades hospitalares: uma revisão sistemática |
title |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review |
spellingShingle |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review Nascimento, Lucas Cerqueira Gomes Barbosa do Pneumonia Farmacorresistência bacteriana Antibacterianos. Bacterial drug resistance Pneumonia Antibacterial. Neumonía Farmacorresistencia bacteriana Antibacteriano. |
title_short |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review |
title_full |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review |
title_fullStr |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review |
title_full_unstemmed |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review |
title_sort |
Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review |
author |
Nascimento, Lucas Cerqueira Gomes Barbosa do |
author_facet |
Nascimento, Lucas Cerqueira Gomes Barbosa do Alves Junior, Gledson Lima Pereira, Vitor Moura Rodrigues , Gerlan da Silva Silva Júnior, Adriano Bezerra da Lemos, André Luís Conceição Santos, Rafael Valença de Souza Nascimento, Adriel Barbosa do |
author_role |
author |
author2 |
Alves Junior, Gledson Lima Pereira, Vitor Moura Rodrigues , Gerlan da Silva Silva Júnior, Adriano Bezerra da Lemos, André Luís Conceição Santos, Rafael Valença de Souza Nascimento, Adriel Barbosa do |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Nascimento, Lucas Cerqueira Gomes Barbosa do Alves Junior, Gledson Lima Pereira, Vitor Moura Rodrigues , Gerlan da Silva Silva Júnior, Adriano Bezerra da Lemos, André Luís Conceição Santos, Rafael Valença de Souza Nascimento, Adriel Barbosa do |
dc.subject.por.fl_str_mv |
Pneumonia Farmacorresistência bacteriana Antibacterianos. Bacterial drug resistance Pneumonia Antibacterial. Neumonía Farmacorresistencia bacteriana Antibacteriano. |
topic |
Pneumonia Farmacorresistência bacteriana Antibacterianos. Bacterial drug resistance Pneumonia Antibacterial. Neumonía Farmacorresistencia bacteriana Antibacteriano. |
description |
Objective: identify the main bacteria resistant to broad drugs associated with the development of pneumonia in hospital patients from 2017 to 2022 worldwide, comparing the agents identified before and during the pandemic due to COVID-19. Methodology: The articles were searched in the Scielo, PubMed and UpToDate databases following the guidelines of the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). The ‘’PVOS’’ strategy (population, variables, outcomes and study) was used to select the articles analyzed in the review. The descriptors standardized by the ‘’Descritores em Ciências da Saúde’’ were used: pneumonia, antibacterials, bacterial drug resistance, bacterial multiple drug resistance for bibliographic survey. Included in this systematic review, analytical observational studies, articles of published research, case studies, systematic reviews and epidemiological, microbiological, and molecular surveillance studies. Results: After the screening process, removal of duplicate articles and analysis of inclusion criteria, 27 articles were identified as eligible for this systematic review. Conclusion: The results of this systematic review provide evidence of the main bacteria causing pneumonia in hospitalized patients worldwide, as well as the resistance profile in the case of multidrug-resistant organisms, in addition to identifying treatment alternatives for these agents. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-26 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34930 10.33448/rsd-v11i13.34930 |
url |
https://rsdjournal.org/index.php/rsd/article/view/34930 |
identifier_str_mv |
10.33448/rsd-v11i13.34930 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34930/29438 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 13; e25111334930 Research, Society and Development; Vol. 11 Núm. 13; e25111334930 Research, Society and Development; v. 11 n. 13; e25111334930 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052772071243776 |